Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00332644 · ClinicalTrials.gov registry record · Phase 4
Smoking Cessation Medications: Efficacy, Mechanisms and Algorithms
A Phase 4 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,504
- Enrollment target
NCT00332644 is a Phase 4 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 1,504 participants.
The verdict
NCT00332644, a Phase 4 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,504 participants
- Enrollment target
Study Summary
The proposed work will advance the understanding and effectiveness of tobacco dependence treatment and result in more smokers quitting successfully.
Interventions
- DRUG nicotine patch
- DRUG bupropion
- DRUG nicotine lozenge
- DRUG nicotine patch + nicotine lozenge
- DRUG bupropion + lozenge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,504 participants |
| Start Date | 2004-09 |
| Est. Completion | 2010-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00332644
The ClinicalTrials.gov registry entry for NCT00332644 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 1,504 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which nicotine patch is the first listed.
NCT00332644 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00332644 about?
NCT00332644 is a clinical study titled "Smoking Cessation Medications: Efficacy, Mechanisms and Algorithms". The proposed work will advance the understanding and effectiveness of tobacco dependence treatment and result in more smokers quitting successfully.
What is the current status of trial NCT00332644?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,504 participants. The study started on 2004-09. Estimated completion is 2010-08.
What interventions are being tested in trial NCT00332644?
The interventions under investigation include: nicotine patch (DRUG), bupropion (DRUG), nicotine lozenge (DRUG), nicotine patch + nicotine lozenge (DRUG), bupropion + lozenge (DRUG).
Who is sponsoring clinical trial NCT00332644?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.